ATSENA THERAPEUTICS
Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness. Atsena has an ongoing Phase I/II clinical trial evaluating a potential therapy for one of the most common causes of blindness in children. Its pipeline of clinical and preclinical assets is powered by adeno-associated virus (AAV) technology tailored to overcome the hurdles presented by inherited retinal disease, and its approach is guided by the specific needs of each patient condition.
ATSENA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.atsenatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
63.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Atsena Therapeutics
Manning Family Foundation
Manning Family Foundation investment in Series A - Atsena Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series A - Atsena Therapeutics
Retinal Degeneration Fund
Retinal Degeneration Fund investment in Series A - Atsena Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - Atsena Therapeutics
Abingworth
Abingworth investment in Series A - Atsena Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Atsena Therapeutics
University of Central Florida
University of Central Florida investment in Series A - Atsena Therapeutics
PBM Capital Group
PBM Capital Group investment in Series A - Atsena Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Atsena Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-16 | Atsena Therapeutics Appoints Linda B. Couto, PhD, as Chief Scientific OfficerDr. Couto strengthens leadership team with extensive AAV and ocular gene therapy expertise |
Official Site Inspections
http://www.atsenatx.com
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
